COVID-19 infection triggers a heightened inflammatory response which in turn, increases thrombosis and thromboembolism. Microvascular thrombosis has been detected in various tissue beds which may account for some of the multi-system organ dysfunction associated with COVID-19. Additional research is needed to understand which prophylactic and therapeutic drug regimens are best for the prevention and treatment of thrombotic complications of COVID-19.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, thrombosis, stroke, Pulmonary embolism, Myocardial infarction, Deep vein thrombosis,
【저자키워드】 COVID-19, SARS-CoV-2, thrombosis, stroke, Pulmonary embolism, Myocardial infarction, Deep vein thrombosis,